The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paulukat, J.
Right arrow Articles by Mühl, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paulukat, J.
Right arrow Articles by Mühl, H.
The Journal of Immunology, 2001, 167: 7038-7043.
Copyright © 2001 by The American Association of Immunologists

Expression and Release of IL-18 Binding Protein in Response to IFN-{gamma}1

Jens Paulukat*, Markus Bosmann2,*, Marcel Nold2,*, Stefanie Garkisch*, Heiko Kämpfer*, Stefan Frank*, Jochen Raedle{dagger}, Stefan Zeuzem{dagger}, Josef Pfeilschifter* and Heiko Mühl3,*

* Pharmazentrum Frankfurt and {dagger} Second Department of Medicine, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany

IL-18 and IL-18 binding protein (IL-18BP) are two newly described opponents in the cytokine network. Local concentrations of these two players may determine biological functions of IL-18 in the context of inflammation, infection, and cancer. As IL-18 appears to be involved in the pathogenesis of Crohn’s disease and may modulate tumor growth, we investigated the IL-18/IL-18BPa system in the human colon carcinoma/epithelial cell line DLD-1. In this study, we report that IFN-{gamma} induces expression and release of IL-18BPa from DLD-1 cells. mRNA induction and secretion of IL-18BPa immunoreactivity were associated with an activity that significantly impaired release of IFN-{gamma} by IL-12/IL-18-stimulated PBMC. Inducibility of IL-18BPa by IFN-{gamma} was also observed in LoVo, Caco-2, and HCT116 human colon carcinoma cell lines and in the human keratinocyte cell line HaCaT. Induction of IL-18BPa in colon carcinoma/epithelial cell lines was suppressed by coincubation with sodium butyrate. IFN-{gamma}-mediated IL-18BPa and its suppression by sodium butyrate were confirmed in organ cultures of intestinal colonic biopsy specimens. In contrast, sodium butyrate did not modulate expression of IL-18. The present data suggest that IFN-{gamma} may limit biological functions of IL-18 at sites of colonic immune activation by inducing IL-18BPa production. Down-regulation of IL-18BPa by sodium butyrate suggests that reinforcement of local IL-18 activity may contribute to actions of this short-chain fatty acid in the colonic microenvironment.




This article has been cited by other articles:


Home page
J Med MicrobiolHome page
T. Ohkusa, T. Yoshida, N. Sato, S. Watanabe, H. Tajiri, and I. Okayasu
Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis
J. Med. Microbiol., May 1, 2009; 58(5): 535 - 545.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. F. Fortin, T. Ear, and P. P. McDonald
Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils
FASEB J, January 1, 2009; 23(1): 194 - 203.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. Ishimaru, R. Arakaki, S. Yoshida, A. Yamada, S. Noji, and Y. Hayashi
Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy
J. Exp. Med., November 24, 2008; 205(12): 2915 - 2927.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. P. Carroll, V. Paunovic, and M. Gadina
Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity
Rheumatology, September 1, 2008; 47(9): 1269 - 1277.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A Platis, Q Yu, D Moore, E. Khojeini, P Tsau, and D. Larson
The effect of daily administration of IL-18 on cardiac structure and function
Perfusion, July 1, 2008; 23(4): 237 - 242.
[Abstract] [PDF]


Home page
JDRHome page
N. Foster, K. Andreadou, L. Jamieson, P.M. Preshaw, and J.J. Taylor
VIP Inhibits P. gingivalis LPS-induced IL-18 and IL-18BPa in Monocytes
Journal of Dental Research, September 1, 2007; 86(9): 883 - 887.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Ziesche, M. Bachmann, H. Kleinert, J. Pfeilschifter, and H. Muhl
The Interleukin-22/STAT3 Pathway Potentiates Expression of Inducible Nitric-oxide Synthase in Human Colon Carcinoma Cells
J. Biol. Chem., June 1, 2007; 282(22): 16006 - 16015.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Bachmann, C. Dragoi, M. A. Poleganov, J. Pfeilschifter, and H. Muhl
Interleukin-18 directly activates T-bet expression and function via p38 mitogen-activated protein kinase and nuclear factor-{kappa}B in acute myeloid leukemia-derived predendritic KG-1 cells
Mol. Cancer Ther., February 1, 2007; 6(2): 723 - 731.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. J. Robertson, J. W. Mier, T. Logan, M. Atkins, H. Koon, K. M. Koch, S. Kathman, L. N. Pandite, C. Oei, L. C. Kirby, et al.
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer.
Clin. Cancer Res., July 15, 2006; 12(14): 4265 - 4273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. A Dinarello
Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 447S - 455S.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
L. Klampfer, J. Huang, T. Sasazuki, S. Shirasawa, and L. Augenlicht
Inhibition of Interferon {gamma} Signaling by the Short Chain Fatty Acid Butyrate
Mol. Cancer Res., September 1, 2003; 1(11): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Plitz, P. Saint-Mezard, M. Satho, S. Herren, C. Waltzinger, M. de Carvalho Bittencourt, M. H. Kosco-Vilbois, and Y. Chvatchko
IL-18 Binding Protein Protects Against Contact Hypersensitivity
J. Immunol., August 1, 2003; 171(3): 1164 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
B. Moller, J. Paulukat, M. Nold, M. Behrens, N. Kukoc-Zivojnov, J. P. Kaltwasser, J. Pfeilschifter, and H. Muhl
Interferon-{gamma} induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes
Rheumatology, March 1, 2003; 42(3): 442 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. K. Banda, A. Vondracek, D. Kraus, C. A. Dinarello, S.-H. Kim, A. Bendele, G. Senaldi, and W. P. Arend
Mechanisms of Inhibition of Collagen-Induced Arthritis by Murine IL-18 Binding Protein
J. Immunol., February 15, 2003; 170(4): 2100 - 2105.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. A. Gracie, S. E. Robertson, and I. B. McInnes
Interleukin-18
J. Leukoc. Biol., February 1, 2003; 73(2): 213 - 224.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Hurgin, D. Novick, and M. Rubinstein
The promoter of IL-18 binding protein: Activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta
PNAS, December 24, 2002; 99(26): 16957 - 16962.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Corbaz, T. ten Hove, S. Herren, P. Graber, B. Schwartsburd, I. Belzer, J. Harrison, T. Plitz, M. H. Kosco-Vilbois, S.-H. Kim, et al.
IL-18-Binding Protein Expression by Endothelial Cells and Macrophages Is Up-Regulated During Active Crohn's Disease
J. Immunol., April 1, 2002; 168(7): 3608 - 3616.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.